The question
Time left and time to effect
The first clock belongs to the organ. Once we know where a biomarker stands and how fast it is moving, the time it has left is the remaining distance to its critical threshold divided by that speed, which means the clock runs faster whenever the organ deteriorates faster.
The second clock belongs to the therapy, because every drug and every procedure needs its own time to reach an effect, which pharmacology sets however urgent the situation has become.
What it adds
What a severity score does not show
The scores used at the bedside today summarise how far a patient's values have moved from normal at this moment. Two patients can share the same score while one is holding steady and the other is hours from a threshold, and a score alone cannot tell them apart.
Because MOISS works from the speed as well as the level, it can separate those two patients, and it can give the same therapy a different grade an hour later if the organ has picked up pace in between.
The grades
What the six grades mean
The grade comes from the margin measured against the therapy's own onset time, since half an hour to spare is generous for a drug that acts in minutes and thin for one that needs most of a day.
The grades in the middle exist because lateness is rarely all or nothing. A therapy that lands shortly after the threshold can still recover part of what was lost, and one that lands later may be worth giving alongside a bridging therapy that buys the organ time.
| PROPHYLACTIC | The therapy takes effect with more than its own onset time to spare. |
| ON_TIME | It takes effect before the organ reaches the threshold. |
| PARTIAL | It takes effect shortly after the threshold is crossed. |
| MARGINAL | It takes effect later still, in the period where bridging therapy may help. |
| FUTILE | It takes effect well past the threshold, with little left to recover. |
| TOO_LATE | It cannot take effect before the damage is irreversible. |
Evidence
How far it has been tested
So far the grading has been tested retrospectively, against records from public critical care databases. A prospective study at the bedside is still ahead, and until it is done the grades should be read as research.
We review each request and reply by email.
- Tested
- Retrospectively, against records from public critical care databases.
- Still ahead
- A prospective study at the bedside.
- Status
- Research, awaiting a prospective study before any clinical use.